Oxybutynin Chloride Tablet
Product Images NDC 64980-531

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 64980-531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxybutynin 1000s Count Label

Oxybutynin 1000s Count Label
Label for Oxybutynin Chloride Tablets USP 5 mg oral tablets by Rising Pharma Holdings, Inc. The label indicates a bottle containing 1000 tablets for prescription use only. It includes dosage information, storage instructions, warnings, a barcode, and manufacturer details.*
FDA Label Image

Oxybutynin 100s Count Label

Oxybutynin 100s Count Label
Oxybutynin Chloride Tablets USP 5 mg oral tablets carton label by Rising Pharma Holdings, Inc. The label indicates 100 tablets per container, prescription only, with dosage instructions and storage information included. The product is marked as containing 5 mg strength per tablet.*
FDA Label Image

Oxybutynin 500s Count Label

Oxybutynin 500s Count Label
Oxybutynin Chloride Tablets, USP 5 mg oral tablet label from Rising Pharma Holdings, Inc. The label indicates a bottle size of 500 tablets and specifies Rx only. Storage and dispensing instructions, warnings, and a barcode are also visible on the label.*
FDA Label Image

Oxybutynin Figure1

Oxybutynin Figure1
A line graph showing mean plasma R-Oxybutynin concentration (ng/mL) over 24 hours following administration of Oxybutynin 5 mg taken three times daily (TID). The x-axis represents time in hours, while the y-axis indicates concentration levels, with error bars showing variability at each time point. Concentration peaks occur periodically corresponding to dosing times.*
FDA Label Image

Oxybutynin Figure2

Oxybutynin Figure2
A line graph depicting mean R-Oxybutynin plasma concentration (ng/mL) over time (hours). The x-axis represents time from 0 to 12 hours, and the y-axis shows plasma concentration from 0 to 10 ng/mL. Data points with error bars illustrate the concentration peaking around 1 hour and gradually declining through 12 hours.*
FDA Label Image

Oxybutynin Structure

Oxybutynin Structure
Chemical structure of Oxybutynin Chloride, showing its molecular framework with functional groups, aromatic ring, and chloride salt component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.